Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (3): 638-647.doi: 10.13481/j.1671-587X.20220312
• Research in basic medicine • Previous Articles Next Articles
Xiaochen HUANG1,Hao LI2,Baohua WANG1(
),Kai LI2,3(
)
Received:2021-09-22
Online:2022-05-28
Published:2022-06-21
Contact:
Baohua WANG,Kai LI
E-mail:wbhzyxx@163.com;likai@jlu.edu.cn
CLC Number:
Xiaochen HUANG,Hao LI,Baohua WANG,Kai LI. Protective effect of lidocaine on PC12 cells in Parkinson’s disease model and its mechanism[J].Journal of Jilin University(Medicine Edition), 2022, 48(3): 638-647.
Tab.2
Expression levels of Wnt1 and caspase 3 proteins in PC12 cells in various groups after treated with lidocaine for 6 h"
| Group | Wnt1 | caspase 3 |
|---|---|---|
| Control | 0.360±0.010 | 0.537±0.007 |
| MPTP | 0.035±0.005* | 0.815±0.045* |
| MPTP+0.200 g·L-1 lidocaine | 1.105±0.045*△ | 0.755±0.005* |
| MPTP+0.600 g·L-1 lidocaine | 1.575±0.055*△# | 0.660±0.020△ |
| MPTP+1.000 g·L-1 lidocaine | 0.630±0.008*△#○ | 0.436±0.02△#○ |
| F | 337.0 | 47.21 |
| P | <0.01 | <0.01 |
Tab.4
Levels of IL-1β,IL-6,and TNF-α in supernatant of PC12 cells in various groups [n=3,x±s, ρB/(ng·L-1)]"
| Group | IL-1β | IL-6 | TNF-α |
|---|---|---|---|
| Control | 1.173±0.011 | 98.732±2.576 | 3.135±0.437 |
| MPTP | 1.935±0.083* | 172.561±1.053* | 24.421±1.578* |
| MPTP+lidocaine | 1.203±0.033△ | 1005.020±4.722△ | 6.081±1.387△ |
| MPTP+lidocaine+DKK1 | 2.122±0.003*# | 157.634±0.726*# | 33.186±0.240*△# |
| MPTP+DKK1 | 2.834±0.011*△#○ | 161.525±4.615*# | 29.030±0.530*# |
| F | 92.38 | 292.3 | 1916 |
| P | <0.01 | <0.01 | <0.01 |
Tab.5
Expression levels of Wnt1,β-catenin,GSK-3β,p-GSK-3β,and caspase 3 proteins in PC12 cells in various groups"
| Group | Wnt1 | β-catenin | GSK-3β | p-GSK-3β | caspase 3 |
|---|---|---|---|---|---|
| Control | 0.961±0.008 | 0.975±0.005 | 0.517±0.004 | 0.545±0.005 | 0.544±0.006 |
| MPTP | 0.563±0.011* | 0.408±0.004* | 0.568±0.008* | 0.772±0.014* | 0.580±0.010* |
| MPTP+lidocaine | 0.609±0.011*△ | 0.476±0.010*△ | 0.503±0.004*△ | 0.419±0.004*△ | 0.288±0.003*△ |
| MPTP+lidocaine+DKK1 | 0.399±0.008*△# | 0.340±0.010*△# | 0.729±0.010*△# | 0.519±0.005△# | 0.351±0.021*△# |
| MPTP+DKK1 | 0.427±0.095*△# | 0.490±0.010*△# | 0.721±0.005*△# | 0.575±0.015*△# | 0.705±0.015*△#○ |
| F | 690.2 | 2 325 | 342.5 | 190.6 | 209.5 |
| P | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 |
| 1 | BEITZ J M. Parkinson’s disease: a review[J]. Front Biosci (Schol Ed), 2014, 6(1): 65-74. |
| 2 | REN R T, SUN Y, ZHAO X, et al. Recent advances in biomarkers for Parkinson’s disease focusing on biochemicals, omics and neuroimaging[J]. Clin Chem Lab Med, 2015, 53(10): 1495-1506. |
| 3 | DORSEY E R, CONSTANTINESCU R, THOMPSON J P, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030[J].Neurology,2007,68(5): 384-386. |
| 4 | KALIA L V, LANG A E. Parkinson’s disease[J]. Lancet, 2015, 386(9996): 896-912. |
| 5 | BASSANI T B, VITAL M A B F, RAUH L K. Neuroinflammation in the pathophysiology of Parkinson’s disease and therapeutic evidence of anti-inflammatory drugs[J]. Arq Neuropsiquiatr, 2015, 73(7): 616-623. |
| 6 | CIERI D, BRINI M, CALÌ T. Emerging (and converging) pathways in Parkinson’s disease: keeping mitochondrial wellness[J]. Biochem Biophys Res Commun, 2017, 483(4): 1020-1030. |
| 7 | SHEN L, JI H F. Low uric acid levels in patients with Parkinson’s disease: evidence from meta-analysis[J]. BMJ Open, 2013, 3(11): e003620. |
| 8 | BLAIR H A, DHILLON S. Safinamide: a review in Parkinson’s disease[J].CNS Drugs,2017,31(2): 169-176. |
| 9 | ASCHERIO A, SCHWARZSCHILD M A. The epidemiology of Parkinson’s disease: risk factors and prevention[J]. Lancet Neurol, 2016,15(12):1257-1272. |
| 10 | KEMPERMANN G. Adult neurogenesis: an evolutionary perspective[J]. Cold Spring Harb Perspect Biol, 2015, 8(2): a018986. |
| 11 | FONCK C, BAUDRY M. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation[J]. Brain Res, 2001, 905: 199-206. |
| 12 | MIN C C, CHO D I, KWON K J, et al. Novel regulatory mechanism of canonical Wnt signaling by dopamine D2 receptor through direct interaction with beta-catenin[J]. Mol Pharmacol, 2011, 80(1): 68-78. |
| 13 | 陈博文, 苏 飞, 冉继朋, 等. 利多卡因对大鼠SAH后神经细胞凋亡和迟发性脑血管痉挛的保护作用[J]. 神经解剖学杂志, 2019, 35(6): 641-645. |
| 14 | CHEN Z C, LI G L, LIU J. Autonomic dysfunction in Parkinson’s disease: implications for pathophysiology, diagnosis, and treatment[J]. Neurobiol Dis, 2020, 134: 104700. |
| 15 | PRESSE F, CARDONA B, BORSU L, et al. Lithium increases melanin-concentrating hormone mRNA stability and inhibits tyrosine hydroxylase gene expression in PC12 cells[J]. Brain Res Mol Brain Res, 1997, 52(2): 270-283. |
| 16 | BAYIR H, KAPRALOV A A, JIANG J, et al. Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson’s disease[J]. J Biol Chem, 2009, 284(23): 15951-15969. |
| 17 | KUMAR H, KOPPULA S, KIM I S, et al. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson’s disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death[J]. CNS Neurol Disord Drug Targets, 2012, 11(8): 1015-1029. |
| 18 | BEAL M F. Experimental models of Parkinson’s disease[J]. Nat Rev Neurosci, 2001, 2(5): 325-334. |
| 19 | LANGSTON J W, IRWIN I. MPTP: current concepts and controversies[J]. Clin Neuropharmacol, 1986, 9(6): 485-507. |
| 20 | ZUO L, MOTHERWELL M S. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson’s disease[J]. Gene, 2013, 532(1): 18-23. |
| 21 | JANG J, JUNG Y, KIM Y, et al. LPS-induced inflammatory response is suppressed by Wnt inhibitors, Dickkopf-1 and LGK974[J]. Sci Rep, 2017, 7: 41612. |
| 22 | JIN H B, YU J. Lidocaine protects H9c2 cells from hypoxia-induced injury through regulation of the MAPK/ERK/NF-κB signaling pathway[J]. Exp Ther Med, 2019, 18(5): 4125-4131. |
| 23 | WANG Z X, ZHAO Y, YU Y, et al. Effects of lncRNA SNHG20 on proliferation and apoptosis of non-small cell lung cancer cells through Wnt/β-catenin signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2020, 24(1): 230-237. |
| 24 | LIN S W, JIN P P, SHAO C, et al. Lidocaine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxemia in mice by suppressing HIF1α-induced glycolysis[J]. Int Immunopharmacol, 2020, 80: 106150. |
| 25 | KARNINA R, ARIF S K, HATTA M, et al. Molecular mechanisms of lidocaine[J]. Ann Med Surg (Lond), 2021, 69: 102733. |
| 26 | GORDON M D, NUSSE R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors[J]. J Biol Chem, 2006, 281(32): 22429-22433. |
| 27 | SAIKI S. The association of Parkinson’s disease pathogenesis with inflammation[J]. Rinsho Shinkeigaku, 2014, 54(12): 1125-1127. |
| 28 | 谭小平,丛盛日,向春晨,等.关注遗传性帕金森病[J].中国实用内科杂志,2022,42(4):283-289. |
| 29 | MARCHETTI B, TIROLO C, L'EPISCOPO F,et al. Parkinson’s disease, aging and adult neurogenesis: Wnt/β-catenin signalling as the key to unlock the mystery of endogenous brain repair[J]. Aging Cell, 2020, 19(3): e13101. |
| [1] | Lingyu WANG,Ruili LI,Yu ZHANG,Meitong GUO,Yalong LIANG,Xu HAN,Xiaowei HUANG,Yang ZHANG,Xiuhua YU. Improvement effect of Renshen Jianzhi Tablets on learning and memory ability in cognitive impairment model rats and its protective effect on hippocampal neurons and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 719-729. |
| [2] | Zheng TANG,Wei LIU,Hongmin HU,Qi LAI,Yan SHI,Shengquan LIU,Jun YANG,Chun CHU. Improvement effect of Qishen Yiqi dropping pills on myocardium injury in rats induced by sorafenib and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 308-317. |
| [3] | Ning MA,Shuang LIU,Chengyao WANG,Jiajun LU,Linyu CHEN,Ziyi WANG,Weiqin ZHAO,Weitong WANG,Pengcheng CHE,Hong SUN. Improvement effect of topical application of exosome loaded hydrogel DCC on peritoneal adhesion in mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 318-329. |
| [4] | Ziyi TANG,Shiying YANG,Tianzhen YANG,Wenqiang LIU,Jiangxue ZHONG,Li YIN. Induction effect of pesticide pyraclostrobin on ferroptosis of spermatocytes GC-2 of mice [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 18-25. |
| [5] | Sitong CHEN,Dan YANG,Qingjie LI,Xiaolei TANG,Han WANG,Yangyang LIU,Tiejun LIU. Ameliorative effect of puerarin on non-alcoholic fatty liver disease induced by high-fat diet in mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 44-55. |
| [6] | Yi ZHAO,Bing ZHOU,Huirui QIU,Xuan LI,Xiangli CUI. Improvement effect of lovastatin on hyperlipidemia-induced liver injury in rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1155-1164. |
| [7] | Nan LU,Mingxin DONG,Lei YU,Chengbiao SUN,Yan WANG,Na XU,Wensen LIU,Shumin GE. Transcriptome sequencing-based expression profiling of oxidative stress-related genes and circRNAs in ricin toxin-induced macrophage pyroptosis [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1007-1018. |
| [8] | Yue WANG,Ning MA,Jiajun LU,Chengyao WANG,Linyu CHEN,Yuchen REN,Jingwu LI,Hong SUN. Protective effect of novel composite hydrogels on H₂O₂-induced oxidative stress injury in cardiomyocytes [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 352-359. |
| [9] | Chaohe ZHANG,Xinwei ZHANG,Xiangfeng WANG. Protective effect of Pien-Tze-Huang on acetaminophen-induced liver injury and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 105-114. |
| [10] | Yanyan BAI,Yutong ZHOU,Haijuan SUI,Zhuo LIU. Improvement effect of asiatic acid on damage of lipopolysaccharide-induced hippocampum neuron in rats through Nrf2/HO-1 signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 85-95. |
| [11] | Siqi LI,Guangdao CHEN,Qiyi ZENG. Improvement effect of chrysophanol on hydrogen peroxide-induced apoptosis of EA. hy926 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1512-1518. |
| [12] | Meng QU,Rui HUANG,Xinda JU,Yuxin LIU,Jichen XIA,Jiaxin HUANG,Chunyan YU,Zhiheng DONG. Ameliorative effect of ginsenoside Rh1 on kidney injury in diabetic mice through activation of Nrf2/HO-1 signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1565-1571. |
| [13] | Yi LONG,Ziyi YOU,Xiuying TAN,Rou ZHANG,Yuhan ZHANG,Lina YANG. Protective effect of sodium butyrate on acute liver injury in mice induced by lipopolysaccharide combined with D-galactosamine and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1614-1620. |
| [14] | Haoyu WANG,Yuqi WANG,Bingqian WANG,Jinhan NIE,Jiaqing YAN,Min HU. Inhibitory effect of mesalazine on pro-inflammatory factors and peroxides in RAW264.7 cells and its therapeutic effect on periodontitis model rats [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1250-1258. |
| [15] | Fengmei XIONG,Yuxiang CAI,Zhuo LIU,Na SUN,Yang LI. Alleviatory effect of curcumin on cardiomyocyte toxicity induced by doxorubicin by regulating SIRT3/SOD2 signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1339-1347. |